Cyclical cyclophosphamide and steroids is effective in resistant or relapsing nephrotic syndrome due to M-type phospholipase A2 receptor-related membranous nephropathy after tacrolimus therapy.

Authors :: Ramachandran R
Kumar V
Jha V
Source :: Kidney international [Kidney Int] 2016 Jun; Vol. 89 (6), pp. 1401-2.
Publication Year :: 2016

Subjects :: Adolescent
Adult
Calcineurin Inhibitors therapeutic use
Cyclophosphamide therapeutic use
Drug Therapy, Combination methods
Female
Glomerulonephritis, Membranous immunology
Glomerulonephritis, Membranous urine
Glucocorticoids pharmacology
Glucocorticoids therapeutic use
Humans
Immunosuppressive Agents therapeutic use
Male
Middle Aged
Nephrotic Syndrome immunology
Nephrotic Syndrome urine
Phospholipases A2
Prednisolone pharmacology
Prednisolone therapeutic use
Proteinuria drug therapy
Proteinuria immunology
Proteinuria urine
Recurrence
Respiratory Tract Infections etiology
Tacrolimus pharmacology
Tacrolimus therapeutic use
Treatment Outcome
Young Adult
Cyclophosphamide pharmacology
Drug Resistance
Glomerulonephritis, Membranous drug therapy
Immunosuppressive Agents pharmacology
Nephrotic Syndrome drug therapy
Receptors, Phospholipase A2 immunology

Full Text Access

Tools